Changes in Kawasaki disease incidence and phenotype during the COVID-19 pandemic.

Ünlü, Ayse Mine; Holm, Mette; Krusenstjerna-Hafstrøm, Thomas; Glarup, Mia; Bjerre, Jesper; Herlin, Troels

Ünlü, Ayse Mine; Holm, Mette; Krusenstjerna-Hafstrøm, Thomas; Glarup, Mia; Bjerre, Jesper; Herlin, Troels.

Afiliação

Ünlü AM; Department of Rheumatology, Hospital South West Jutland, University Hospital of Southern Denmark, Esbjerg.
Holm M; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Denmark.
Krusenstjerna-Hafstrøm T; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Denmark.
Glarup M; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Denmark.
Bjerre J; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Denmark.
Herlin T; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Denmark.

Dan Med J ; 70(6)2023 May 15.

Article em En | MEDLINE | ID: mdl-37341355

Assuntos

COVID-19; Síndrome de Linfonodos Mucocutâneos; Humanos; Incidência; Pandemias; Síndrome de Linfonodos Mucocutâneos/epidemiologia; Imunoglobulinas Intravenosas/uso terapêutico; Estudos Retrospectivos; COVID-19/epidemiologia; SARS-CoV-2; Fenótipo

Buscar no Google

Imprimir

XML

PubMed Links

Base de dados: MEDLINE Assunto principal: COVID-19 / Síndrome de Linfonodos Mucocutâneos Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links

Base de dados: MEDLINE Assunto principal: COVID-19 / Síndrome de Linfonodos Mucocutâneos Idioma: En Ano de publicação: 2023 Tipo de documento: Article